Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Up 127.4% in February

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a significant increase in short interest in February. As of February 28th, there was short interest totalling 48,900 shares, an increase of 127.4% from the February 13th total of 21,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Shares of LABFF remained flat at C$65.86 during midday trading on Friday. The firm’s fifty day simple moving average is C$65.86 and its 200 day simple moving average is C$77.03. Laboratorios Farmaceuticos Rovi has a 1 year low of C$65.86 and a 1 year high of C$65.86.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.